Lisa Selby
Nurse Practitioner · El Paso, TXNPI 1811599665
Payments from drug & device makers
Across 837 payments — averaging $22.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Novo Nordisk$2K
- Amgen$2K
- Dexcom, Inc.$2K
- Lilly USA, LLC$1K
- Insulet Corporation$828
- plus $8K from 38 others
What the payments were for
- Travel & lodging$2,12611%
- Food & beverage$16,33488%
- Education$690%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,529 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KorlymMifepristone | 38 | $1,265,305 |
| MounjaroTirzepatide | 627 | $1,170,181 |
| OzempicSemaglutide | 408 | $914,589 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 252 | $300,183 |
| JardianceEmpagliflozin | 213 | $251,267 |
| FarxigaDapagliflozin Propanediol | 215 | $243,047 |
| TrulicityDulaglutide | 104 | $225,580 |
| ProliaDenosumab | 119 | $207,416 |
| Xigduo XrDapaglifloz Propaned/Metformin | 146 | $176,536 |
| VascepaIcosapent Ethyl | 211 | $176,116 |
| KerendiaFinerenone | 172 | $145,979 |
| Humalog Kwikpen U-200Insulin Lispro | 53 | $133,178 |
| Tresiba Flextouch U-200Insulin Degludec | 91 | $125,746 |
| RybelsusSemaglutide | 56 | $110,704 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 69 | $101,270 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $1,474 | $1,411,802765 claims |
| Corcept TherapeuticsKorlym | $745 | $1,265,30538 claims |
| Novo NordiskOzempic, Rybelsus | $2,091 | $1,025,293464 claims |
| Boehringer IngelheimSynjardy Xr, Jardiance, Synjardy | $417 | $583,265489 claims |
| AstraZenecaFarxiga | $548 | $243,047215 claims |
| AmgenProlia | $1,626 | $207,416119 claims |
| BayerKerendia | $806 | $145,979172 claims |
| Radius Health, Inc.Tymlos | $375 | $63,88314 claims |
| MerckJanuvia, Janumet | $214 | $58,32352 claims |
| AbbVieLinzess, Synthroid | $560 | $48,996156 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $309 | $18,01615 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $243 | $17,36517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in El Paso
- Amanda FrenchEl Paso$61K
- Miguel RodriguezEl Paso$17K
- Nanette PettryEl Paso$16K
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Kelly BrassilHouston$194K
- Corrie BerkSan Antonio$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.